Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Quantifying the Size and Diversity of the Human Alloresponse Via High-Throughput T Cell Receptor Sequencing

Susan Dewolf, MD, Boris Grinshpun, Thomas Savage, Sai ping Lau, Aleksandar Obradovic, Brittany Shonts, Suxiao Yang, Heather Morris, MD, Julien Zuber, MDPhD, Robert Winchester, MD, Megan Sykes, MD, Yufeng Shen, PhD

Blood (2017) 130 (Supplement 1): 1898.

https://doi.org/10.1182/blood.V130.Suppl_1.1898.1898

Published: 2017

Journal Articles

Enforced Co-Stimulation and Co-Inhibitory Blockade Synergize to Enhance the Functions of Exhausted CTL

Barry Flutter, PhD, Noha Edwards, Lei Zhang, Shivajanani Sivakumaran, Michael Croft, PhD, Megan Sykes, MD, Ronjon Chakraverty, MD, PhD

Blood (2011) 118 (21): 1911.

https://doi.org/10.1182/blood.V118.21.1911.1911

Published: 2011

Journal Articles

Long Term Follow-up of Recipients of Combined HLA-Matched Nonmyeloablative Bone Marrow and Kidney Transplantation for Multiple Myeloma with End-Stage Renal Disease.

Thomas R Spitzer, MD, Megan Sykes, MD, Nina Tolkoff Rubin, MD, Tatsuo Kawai, MD, Steven L McAfee, MD, Bimalangshu Dey, MD, PhD, Karen Ballen, MD, Francis Delmonico, MD, Susan Saidman, PhD, David H Sachs, M.D., Benedict Cosimi, MD

Blood (2009) 114 (22): 3368.

https://doi.org/10.1182/blood.V114.22.3368.3368

Published: 2009

Journal Articles

Persistence of Donor-Derived Protein in Host Myeloid Cells After Induced Rejection of Engrafted Allogeneic Bone Marrow Cells.

Toshiki Saito, MD, PhD, Joji Fujisaki, MD, Alicia Carlson, PhD, Charles P. Lin, PhD, Megan Sykes, MD, PhD

Blood (2009) 114 (22): 63.

https://doi.org/10.1182/blood.V114.22.63.63

Published: 2009

Journal Articles

Peripheral Alloantigen Drives Early Dysfunction and Eventual Exhaustion of CTL Following Delayed Donor Leukocyte Infusions.

Barry R Flutter, PhD, Farnaz Fallah-Arani, PhD, Clare Bennett, PhD, Janani Sivakumaran, Gordon J Freeman, PhD, Megan Sykes, MD, PhD, Ronjon Chakraverty, MD, PhD

Blood (2008) 112 (11): 2346.

https://doi.org/10.1182/blood.V112.11.2346.2346

Published: 2008

Journal Articles

Characterization of NK1.1 + CD8 T Cells in Allogeneic Hematopoietic Cell Transplantation Recipients

Yi Wang, Hui Wang, MD, PhD, Shumei Wang, Megan Sykes, MD, Yong-Guang Yang, MD, PhD

Blood (2008) 112 (11): 4616.

https://doi.org/10.1182/blood.V112.11.4616.4616

Published: 2008

Journal Articles

Lack of “Bystander” Activation and Evidence for Competition for Resources among Gvh-Reactive CD4 T Cells

Giovanna Andreola, MD, Meredith Chittenden, Megan Sykes, MD

Blood (2008) 112 (11): 3507.

https://doi.org/10.1182/blood.V112.11.3507.3507

Published: 2008

Journal Articles

Host Environment Determines the Development of Gvhd but Not the Extent of Activation and Expansion of Gvh-Reactive CD4 T Cells

Giovanna Andreola, MD, Meredith Chittenden, Megan Sykes, MD

Blood (2008) 112 (11): 3508.

https://doi.org/10.1182/blood.V112.11.3508.3508

Published: 2008

Journal Articles

Clonal Expansion of Graft-Versus-Host Reactive CD8+ T Cells Is Dissociated from Full Effector Differentiation Following Delayed DLI.

Ronjon Chakraverty, MD, Barry Flutter, PhD, Hyeon-Seok Eom, MD, Farnaz Fallah-Arani, PhD, Guiling Zhao, Megan Sykes, MD

Blood (2007) 110 (11): 2170.

https://doi.org/10.1182/blood.V110.11.2170.2170

Published: 2007

Journal Articles

Targeting CD134 Results in Selective Depletion of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors.

Xupeng Ge, MD, PhD, Megan Sykes, MD, Julia Brown, PhD, Vassiliki A. Boussiotis, MD, PhD

Blood (2007) 110 (11): 2174.

https://doi.org/10.1182/blood.V110.11.2174.2174

Published: 2007

Journal Articles

Lymphopenia Promotes the Development of Graft-Versus-Host Disease upon Donor Leukocyte Infusion.

Jessica Sachs, MD, Megan Sykes, MD

Blood (2007) 110 (11): 2185.

https://doi.org/10.1182/blood.V110.11.2185.2185

Published: 2007

Journal Articles

Non-Myeloablative T-Cell Depleted (TCD) Haploidentical Hematopoietic Cell Transplantation (HCT) Followed by Donor Leukocyte Infusion(s) for Hematologic Malignancies: The MGH Experience.

Bimalangshu R. Dey, MD, PhD, Andrew J. Yee, MD, Steven McAfee, MD, Christine Dube, Karen Ballen, MD, Eyal Attar, MD, Christine Colby, Susan Saidman, PhD, Karen Malikowski, Frederic Preffer, PhD, Megan Sykes, MD, Thomas R. Spitzer, MD

Blood (2007) 110 (11): 5088.

https://doi.org/10.1182/blood.V110.11.5088.5088

Published: 2007

Journal Articles

NK1.1 + Cells Are Involved in the Anti-Tumor Immunity Induced by the Rejection of Donor Hematopoietic Cells in Mixed Bone Marrow Chimeras.

Toshiki I. Saito, MD, PhD, Megan Sykes, MD

Blood (2006) 108 (11): 3166.

https://doi.org/10.1182/blood.V108.11.3166.3166

Published: 2006

Journal Articles

Specific Non-Responsiveness to Pig in Baboons Receiving BMT from GalT-KO Pigs.

Ahmed Ghazi, Adam Griesemer, MD, Masayoshi Okumi, MD, Erica Hirsh, Diana Lo, Megan Sykes, MD, David H. Sachs, MD, Kazuhiko Yamada, MD, PhD, Christene A. Huang, PhD

Blood (2006) 108 (11): 5265.

https://doi.org/10.1182/blood.V108.11.5265.5265

Published: 2006

Journal Articles

In Vivo and Ex Vivo T-Cell Depleted (TCD) NonmyeloablativeHaploidentical Stem Cell Transplantation (NSCT) for Hematologic Malignancy (HM).

Thomas R. Spitzer, MD, Steven L. McAfee, MD, Dey R. Bimalangshu, MD, Karen Ballen, MD, Eyal Attar, MD, Christine Colby, PharmD, Fred Preffer, PhD, Susan Saidman, PhD, Juanita Shaffer, David H. Sachs, MD, Megan Sykes, MD

Blood (2005) 106 (11): 5431.

https://doi.org/10.1182/blood.V106.11.5431.5431

Published: 2005

Journal Articles

Long-Lasting Anti-Tumor Immunity Induced by the Rejection of Donor Hematopoietic Cells in Mixed Bone Marrow Chimeras.

Toshiki I. Saito, MD, PhD, Megan Sykes, MD

Blood (2005) 106 (11): 1319.

https://doi.org/10.1182/blood.V106.11.1319.1319

Published: 2005

Journal Articles

Outcomes of Patients with Engraftment Syndrome (ES) Following Nonmyeloablative Hematopoietic Stem Cell Transplant (SCT) for Hematologic Malignancy(HM).

Erica Linden, MD, Steven L. McAfee, MD, Bimalangshu R. Dey, MD, Karen Ballen, MD, Susan Saidman, PhD, Christine Colby, PharmD, Megan Sykes, MD, Thomas R. Spitzer, MD

Blood (2005) 106 (11): 3661.

https://doi.org/10.1182/blood.V106.11.3661.3661

Published: 2005

Journal Articles

Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

David T. Ting, MD, Bimalangshu Dey, MD, Ahmed Chaudhary, Christine Colby, Karen Power, Steven McAfee, MD, Karen Ballen, MD, Eyal Attar, MD, Susan Saidman, Frederick Preffer, Robert Sackstein, MD, PhD, Juanita Shaffer, Megan Sykes, MD, Thomas R. Spitzer, MD

Blood (2005) 106 (11): 3665.

https://doi.org/10.1182/blood.V106.11.3665.3665

Published: 2005

Journal Articles

Minimal HLA Disparity and KIR Ligand Compatibility in Host Versus Graft Direction May Facilitate Donor Engraftment Following In Vivo and Ex Vivo T Cell Depleted (TCD) Nonmyeloablative Haploidentical Stem Cell Transplantation for Hematologic Malignancies.

Andrew J. Yee, MD, Thomas R. Spitzer, MD, Susan L. Saidman, PhD, Juanita Shaffer, Karen A. Power, Steven L. McAfee, MD, Karen K. Ballen, MD, Eyal C. Attar, MD, Frederic I. Preffer, PhD, Megan Sykes, MD, Bimalangshu R. Dey, MD

Blood (2005) 106 (11): 3668.

https://doi.org/10.1182/blood.V106.11.3668.3668

Published: 2005

Journal Articles

Sequential Blockade and Engagement of Co-Stimulatory Pathways: A Potential Strategy for Amplifying Graft-Versus-Leukemia Responses without GVHD.

Ronjon Chakraverty, MD PhD, Jennifer Buchli, BA, Guiling Zhao, Richard Hsu, Michael Croft, PhD, Megan Sykes, MD

Blood (2004) 104 (11): 3075.

https://doi.org/10.1182/blood.V104.11.3075.3075

Published: 2004

NARROW

Quantifying the Size and Diversity of the Human Alloresponse Via High-Throughput T Cell Receptor Sequencing

Enforced Co-Stimulation and Co-Inhibitory Blockade Synergize to Enhance the Functions of Exhausted CTL

Long Term Follow-up of Recipients of Combined HLA-Matched Nonmyeloablative Bone Marrow and Kidney Transplantation for Multiple Myeloma with End-Stage Renal Disease.

Persistence of Donor-Derived Protein in Host Myeloid Cells After Induced Rejection of Engrafted Allogeneic Bone Marrow Cells.

Peripheral Alloantigen Drives Early Dysfunction and Eventual Exhaustion of CTL Following Delayed Donor Leukocyte Infusions.

Characterization of NK1.1 + CD8 T Cells in Allogeneic Hematopoietic Cell Transplantation Recipients

Lack of “Bystander” Activation and Evidence for Competition for Resources among Gvh-Reactive CD4 T Cells

Host Environment Determines the Development of Gvhd but Not the Extent of Activation and Expansion of Gvh-Reactive CD4 T Cells

Clonal Expansion of Graft-Versus-Host Reactive CD8+ T Cells Is Dissociated from Full Effector Differentiation Following Delayed DLI.

Targeting CD134 Results in Selective Depletion of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors.

Lymphopenia Promotes the Development of Graft-Versus-Host Disease upon Donor Leukocyte Infusion.

Non-Myeloablative T-Cell Depleted (TCD) Haploidentical Hematopoietic Cell Transplantation (HCT) Followed by Donor Leukocyte Infusion(s) for Hematologic Malignancies: The MGH Experience.

NK1.1 + Cells Are Involved in the Anti-Tumor Immunity Induced by the Rejection of Donor Hematopoietic Cells in Mixed Bone Marrow Chimeras.

Specific Non-Responsiveness to Pig in Baboons Receiving BMT from GalT-KO Pigs.

In Vivo and Ex Vivo T-Cell Depleted (TCD) NonmyeloablativeHaploidentical Stem Cell Transplantation (NSCT) for Hematologic Malignancy (HM).

Long-Lasting Anti-Tumor Immunity Induced by the Rejection of Donor Hematopoietic Cells in Mixed Bone Marrow Chimeras.

Outcomes of Patients with Engraftment Syndrome (ES) Following Nonmyeloablative Hematopoietic Stem Cell Transplant (SCT) for Hematologic Malignancy(HM).

Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Minimal HLA Disparity and KIR Ligand Compatibility in Host Versus Graft Direction May Facilitate Donor Engraftment Following In Vivo and Ex Vivo T Cell Depleted (TCD) Nonmyeloablative Haploidentical Stem Cell Transplantation for Hematologic Malignancies.

Sequential Blockade and Engagement of Co-Stimulatory Pathways: A Potential Strategy for Amplifying Graft-Versus-Leukemia Responses without GVHD.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only